Related Experiment Video
Updated: May 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Coronary thrombus in ST elevation myocardial infarction and atrial fibrillation
Reuben Ilia1, Jean Marc Weinstein, Arik Wolak
1Cardiology Department, Soroka Medical Center, Ben-Gurion University of the Negev, 151, Beer-Sheva, Israel. iliar@bgu.ac.il
Insights
Atrial fibrillation (AF) significantly increases the risk of coronary embolization, a rare cause of acute myocardial infarction (AMI). Patients with AF and AMI show a high incidence of globular filling defects, suggesting emboli.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Coronary artery embolization is an uncommon etiology for acute myocardial infarction (AMI).
- Atrial fibrillation (AF) is a recognized source of systemic emboli.
- Limited literature exists on coronary embolization in the context of AF and AMI.
Purpose of the Study:
- To determine the incidence of coronary emboli in patients with ST-elevation AMI and AF.
- To investigate the association between AF and coronary artery filling defects suggestive of embolization.
Main Methods:
- Retrospective analysis of 2,067 patients with AMI, single-vessel disease, and AF between 2002-2011.
- Comparison with a control group of AMI patients in sinus rhythm.
- Multivariable analysis to identify independent predictors of coronary filling defects.
Main Results:
- 14 patients met criteria for AF, AMI, and single-vessel disease.
- 86% (12/14) of the AF group had globular filling defects, versus 27% (8/30) in the control group (p < 0.01).
- Atrial fibrillation was the sole independent predictor of globular filling defects (OR 34, 95% CI: 2-72).
Conclusions:
- Globular filling defects are frequently observed in patients with AF and single-vessel disease presenting with AMI.
- These defects are likely indicative of coronary artery embolization originating from AF.
- Inadequate anticoagulation was noted in most patients with AF and coronary emboli.
Abstract:
Coronary embolization is a rare cause of acute myocardial infarction (AMI) and few descriptions are found in the literature. Since atrial fibrillation is a known cause of systemic embolization our aim was to investigate the incidence of globular filling defects suggesting embolization in patients presenting with atrial fibrillation (AF) and ST elevation AMI with single vessel disease. We retrospectively analyzed all patients from our data base between 2002 and 2011 (2,067 patients) presenting with AF, AMI and single vessel disease and compared them to a randomly chosen control group with AMI, single vessel disease and in sinus rhythm. Of the 14 patients meeting the above criteria, 12 had a globular filling defect at the occlusion site (86%), in comparison to only 8 of 30 in the control group (27%) (p < 0.01). The study group patients were older, more frequently female, diabetic, dyslipidemic and hypertensive and had more valvular heart disease, while patients in the control group were more often smokers. Almost all the patients in the study group were either not receiving anticoagulation or inadequately anticoagulated. Atrial fibrillation was found to be the only factor independently associated with a globular filling defect on multivariable analysis (OR 34, 95% CI: 2-72). In conclusion, a globular filling defect is a common finding in patients with AF and single vessel disease presenting with AMI, probably as a result of embolization.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins